INGELHEIM, Germany. - Monday, August 25th 2014
HOT LINE: New results from RE-LY® compare the effect of warfarin and Pradaxa® on kidney function in patients requiring anticoagulation
HOT LINE: GLORIA™-AF Registry Program benchmarks patient characteristics and antithrombotic use for stroke prevention in AF worldwide
For Non-US/Non-UK/Non-Canadian Media
New Pradaxa® (dabigatran etexilate) data for the treatment of a broad range of thromboembolic diseases will be presented at the ESC Congress 2014, 30th August – 3rd September, 2014, Barcelona, Spain, organised by the European Society of Cardiology. Study results, including data being presented in two Hot Line sessions, will provide further clinical insights for Pradaxa® and help inform future anticoagulation treatment decisions.
On August 31st, the Registry Hot Line session will reveal data from the first 10,000 pat
Read more »